METHYLPHENIDATE ER 18 MG TAB

Methylphenidate Hydrochloride
$0.5911per EA
DEA Schedule CII

Strength

18 mg/1

Manufacturer

AvPAK

NDC

50268054512

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA211009

On Market Since

4/22/2021

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulation

Price History

1W

0.0%

1M

-2.9%

3M

-8.6%

6M

-15.4%

1Y

-17.4%

3Y

-17.2%

5Y

N/A

All

-36.1%